Health
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023. Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities […]
Read More
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. […]
Read More
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA says
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the Food and Drug Administration said on Friday. The FDA’s decision will threaten the […]
Read More
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016. Mike Blake | Reuters UnitedHealthcare is in hot water again as the insurance giant grapples with a reported government investigation of its Medicare billing practices, pursues employee buyouts and potential layoffs and […]
Read More
Eli Lilly aims to invest in ‘big problems hiding in plain sight’ using obesity windfall
Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer’s. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 drugs, wants to make big bets. These are the ideas that are “hiding in plain sight,” said Lilly Chief Scientific Officer Dan Skovronsky. They’re places where other pharmaceutical companies might not […]
Read More
From pills to new uses, here’s what Eli Lilly’s top scientist sees as the future of weight loss drugs
Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a shot that could be even more powerful than Zepbound. And […]
Read More
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol. That’s according to new government-funded research […]
Read More
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
Hims & Hers Health announced Wednesday it has acquired New Jersey-based at-home lab testing facility Trybe Labs. The deal will allow the telehealth company to offer at-home blood draws and more comprehensive pre-treatment testing to its users. “Access to richer data allows us to deepen the insights that providers can use on our platform to […]
Read More
Measles outbreak grows bigger in rural Texas, and officials expect more cases
A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services clinic in Seattle, Washington. Lindsey Wasson | Reuters At least 58 new cases of measles have been reported across northwest Texas in recent weeks, state health officials said Tuesday, in a “highly contagious” outbreak that might be linked to […]
Read More
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
Starting in his early teens, Deshawn “DJ” Chow wasn’t sure he’d ever be able to live a normal life. Crushing pain episodes brought on by his sickle cell disease were getting progressively worse. “It’s just been hard skipping school and always being in and out of the hospital,” the 19-year-old said. “And just severe […]
Read More